Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
MANGALAM.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
1.41
vs NA
Q4.22
N/A
0.27
vs NA
Q1.23
N/A
-2.77
vs 4.23
Q2.23
N/A
-6.02
vs 1.9
Q3.23
N/A
-2.25
vs 1.41
Q4.23
+17%
0.31
vs 0.27
Q1.24
+180%
2.23
vs -2.77
Q2.24
+128%
1.7
vs -6.02
Q3.24
+175%
1.7
vs -2.25
Q4.24
+157%
0.81
vs 0.31
Sales Growth
YoY
Current
Estimates
Q3.22
-7%
1.1B vs 1.1B
Q4.22
-34%
620.9M vs 938.4M
Q1.23
-22%
940.4M vs 1.2B
Q2.23
-19%
870M vs 1.1B
Q3.23
-23%
813.7M vs 1.1B
Q4.23
+56%
970.5M vs 620.9M
Q1.24
+9%
1B vs 940.4M
Q2.24
-12%
764.9M vs 870M
Q3.24
-2%
797.5M vs 813.7M
Q4.24
-9%
885.5M vs 970.5M
Return on Equity
QoQ
Q1.23
-3%
-0.03
vs 0
Q2.23
-6%
-0.06
vs -0.03
Q3.23
-3%
-0.03
vs -0.06
Q4.23
+0%
0
vs -0.03
Q1.24
+3%
0.03
vs 0
Q2.24
+2%
0.02
vs 0.03
Q3.24
+2%
0.02
vs 0.02
Q4.24
NA
NA
vs 0.02
Institutionnal Ownership
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.
NSE
1.35Â ( 1.68%)
After-hours NaN$0.00 (0.00%)
Relative Strenght
Volume Buzz
-33%
Earning Acce
No
Dist 52w H.
44%Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How MANGALAM.NS compares to sector?